Financials

  • Market Capitalization 16.37 M
  • Employee 5
  • Founded 2020
  • CEO N/A
  • Website www.pasithea.com
  • Headquarter Delaware, United States
  • FIGI BBG01018ZGY8
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.44
Price to sales ratio
72.44

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4680
CYCN
Cyclerion Therapeutics, Inc. - Common Stock
3.70 USD-4.64%+7.25%+11.78%+13.85%16.02 M USD
4682
HOWL
Werewolf Therapeutics, Inc. - Common Stock
0.32 USD-5.88%+3.23%-15.79%-75.38%15.55 M USD
4700
HIND
Vyome Holdings, Inc. - Common Stock
2.24 USD0.00%+2.75%+3.23%-84.29%15.72 M USD
4706
AKTX
Akari Therapeutics Plc - American Depositary Shares
13.10 USD-2.24%+10.64%-2.60%+1080.18%14.99 M USD

Frequently asked questions about Pasithea Therapeutics Corp. - Common Stock

What is the Pasithea Therapeutics Corp. - Common Stock stock price today?

The current price of Pasithea Therapeutics Corp. - Common Stock (KTTA) is 0.49. Over the past 24 hours, the stock has changed by 0.00%. Follow the KTTA chart for real-time price dynamics.

What is the stock ticker of Pasithea Therapeutics Corp. - Common Stock?

Pasithea Therapeutics Corp. - Common Stock trades under the ticker KTTA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Pasithea Therapeutics Corp. - Common Stock stock going up?

KTTA has changed by -3.92% over the last week, -15.52% over the last month, and -28.99% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Pasithea Therapeutics Corp. - Common Stock net income for the last quarter?

Pasithea Therapeutics Corp. - Common Stock reported net income of -2.87 M for the last quarter. The previous quarter showed -10.11 M, which means net income changed by +71.62%.

How many employees does Pasithea Therapeutics Corp. - Common Stock have?

As of the latest available data, Pasithea Therapeutics Corp. - Common Stock has 5 employees. Workforce size can provide additional context about the company's scale and operations.

What is Pasithea Therapeutics Corp. - Common Stock EBITDA?

Pasithea Therapeutics Corp. - Common Stock EBITDA is -1.79 M, and its EBITDA margin is 18.82 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Pasithea Therapeutics Corp. - Common Stock stock?

You can buy Pasithea Therapeutics Corp. - Common Stock (KTTA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Pasithea Therapeutics Corp. - Common Stock stock?

Investing in Pasithea Therapeutics Corp. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KTTA chart and related analysis on metatrader.com as part of your research.

News